Ligand Pharmaceuticals reported $76.74M in Debt for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acorda Therapeutics ACOR:US USD 167.03M 20.66M
Agenus AGEN:US USD 13.16M 299K
Amgen AMGN:US USD 38.94B 241M
Baxter International BAX:US USD 16.64B 204M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Clovis Oncology CLVS:US USD 660.38M 13.49M
Enanta Pharmaceuticals ENTA:US USD 1.42M 0
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
GlaxoSmithKline GSK:LN GBP 20.99B 1.13B
Glaxosmithkline GSK:US GBP 20.99B 1.13B
Harsco HSC:US USD 1.36B 15.58M
Heron Therapeutics HRTX:US USD 149.28M 50K
Insmed INSM:US USD 1.16B 348.29M
Intrexon XON:US USD 43.22M 38.85M
Karyopharm Therapeutics KPTI:US USD 302.82M 69K
Lannett LCI:US USD 623.86M 4.51M
Ligand Pharmaceuticals LGND:US USD 76.74M 92K
Pacira Pharmaceuticals PCRX:US USD 689.47M 58.4M
Rigel Pharmaceuticals RIGL:US USD 39.45M 20K
Spectrum Pharmaceuticals SPPI:US USD 28.67M 178K
Teva Pharmaceutical Industries TEVA:US USD 21.21B 54M
Veracyte VCYT:US USD 400K 1.29M